Suppr超能文献

厄他培南在骨组织和滑膜组织中的扩散。

Diffusion of ertapenem into bone and synovial tissues.

作者信息

Boselli E, Breilh D, Djabarouti S, Bel J C, Saux M C, Allaouchiche B

机构信息

Department of Anaesthesiology and Intensive Care, Edouard Herriot, Lyon, France.

出版信息

J Antimicrob Chemother. 2007 Oct;60(4):893-6. doi: 10.1093/jac/dkm296. Epub 2007 Aug 17.

Abstract

OBJECTIVES

The degree of penetration of an antibiotic into the infected site is an important criterion for therapeutic success. Ertapenem is a new carbapenem, exhibiting activity against most Gram-positive and Gram-negative aerobic and anaerobic bacteria commonly recovered from community-acquired infections. However, no studies concerning its diffusion into bone and synovial tissue are available. Our objective was to quantify ertapenem bone and synovial tissue penetration and to compare our data with the MIC(90)s for causative pathogens.

PATIENTS AND METHODS

In an open-label study, 18 patients who were undergoing elective total hip replacement received a single, parenteral, 1 g dose of ertapenem. One serum, one cortical and cancellous bone and one synovial tissue sample was collected per patient a median [interquartile range (IQR)] of 1.6 (1.5-1.7), 12.4 (11.9-13.1) or 23.8 h (22.6-25.2) later and analysed by HPLC.

RESULTS

The median (IQR) serum concentrations of ertapenem were 70.1 (56.1-75.9), 10.0 (9.1-11.2) and 2.6 mg/L (2.3-3.0), respectively, at the different time points. The median (IQR) cancellous bone tissue concentrations were 13.2 (10.2-14.8), 1.9 (1.7-2.1) and 0.6 microg/g (0.4-0.6) at the different time points, corresponding to a median (IQR) tissue/serum penetration ratio of 0.19 (0.18-0.23). The median (IQR) cortical bone tissue concentrations were 8.0 (6.5-9.5), 1.3 (1.2-1.3) and 0.3 microg/g (0.3-0.4) at the different time points, corresponding to a median (IQR) tissue/serum penetration ratio of 0.13 (0.12-0.14). The median (IQR) synovial tissue concentrations were 26.2 microg/g (22.7-28.4), 4.0 mg/L (3.7-4.4) and 1.0 mg/L (0.9-1.2) at the different time points, corresponding to a median (IQR) tissue/serum penetration ratio of 0.41 (0.39-0.42).

CONCLUSIONS

The concentrations after an ertapenem 1 g dose achieved in cancellous and cortical bone tissue and in synovial tissue were greater than the MIC(90)s for most aerobic organisms for 24 h, and for 12 to 24 h for anaerobic bacteria in healthy volunteers undergoing total hip replacement.

摘要

目的

抗生素渗入感染部位的程度是治疗成功的一项重要标准。厄他培南是一种新型碳青霉烯类抗生素,对从社区获得性感染中常见分离出的大多数革兰氏阳性和革兰氏阴性需氧及厌氧菌均有活性。然而,尚无关于其在骨组织和滑膜组织中扩散情况的研究。我们的目的是量化厄他培南在骨组织和滑膜组织中的渗透情况,并将我们的数据与致病病原体的 MIC(90) 值进行比较。

患者和方法

在一项开放标签研究中,18 例接受择期全髋关节置换术的患者接受了单次 1 g 静脉注射剂量的厄他培南。每位患者在中位数 [四分位间距 (IQR)] 为 1.6 (1.5 - 1.7)、12.4 (11.9 - 13.1) 或 23.8 小时 (22.6 - 25.2) 后采集一份血清、一份皮质骨和松质骨以及一份滑膜组织样本,并通过高效液相色谱法进行分析。

结果

在不同时间点,厄他培南的血清浓度中位数 (IQR) 分别为 70.1 (56.1 - 75.9)、10.0 (9.1 - 11.2) 和 2.6 mg/L (2.3 - 3.0)。在不同时间点,松质骨组织浓度中位数 (IQR) 分别为 13.2 (10.2 - 14.8)、1.9 (1.7 - 2.1) 和 0.6 μg/g (0.4 - 0.6),对应的组织/血清渗透比中位数 (IQR) 为 0.19 (0.18 - 0.23)。在不同时间点,皮质骨组织浓度中位数 (IQR) 分别为 8.0 (6.5 - 9.5)、1.3 (1.2 - 1.3) 和 0.3 μg/g (0.3 - 0.4),对应的组织/血清渗透比中位数 (IQR) 为 0.13 (0.12 - 0.14)。在不同时间点,滑膜组织浓度中位数 (IQR) 分别为 26.2 μg/g (22.7 - 28.4)、4.0 mg/L (3.7 - 4.4) 和 1.0 mg/L (0.9 - 1.2),对应的组织/血清渗透比中位数 (IQR) 为 0.41 (0.39 - 0.42)。

结论

在接受全髋关节置换术的健康志愿者中,1 g 剂量的厄他培南在松质骨和皮质骨组织以及滑膜组织中所达到的浓度,对于大多数需氧菌在 24 小时内高于 MIC(90) 值,对于厌氧菌在 12 至 24 小时内高于 MIC(90) 值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验